Back to
SCHRODER INVESTMENT MANAGEMENT GROUP
ADPT
Showing 0 of 6 quarters
Position history for
SCHRODER INVESTMENT MANAGEMENT GROUP's holdings in ADAPTIVE BIOTECHNOLOGIES COR
No. Schroder Investment Management Group exited its ADPT (Adaptive Biotechnologies) position in Q1 2024. Its Q4 2023 13F listed 365,656 shares worth $1.8M. Schroder Investment Management Group first reported ADPT in Q4 2022 and held it in 5 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.